These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24992280)

  • 1. Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.
    van Hoeijen DA; Blom MT; Tan HL
    Expert Opin Pharmacother; 2014 Sep; 15(13):1875-87. PubMed ID: 24992280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
    Smits JP; Blom MT; Wilde AA; Tan HL
    Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardiac sodium channel: gating function and molecular pharmacology.
    Balser JR
    J Mol Cell Cardiol; 2001 Apr; 33(4):599-613. PubMed ID: 11273715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations.
    Liu H; Tateyama M; Clancy CE; Abriel H; Kass RS
    J Gen Physiol; 2002 Jul; 120(1):39-51. PubMed ID: 12084774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
    Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic overlap of cardiac sodium channelopathies: individual-specific or mutation-specific?
    Makita N
    Circ J; 2009 May; 73(5):810-7. PubMed ID: 19336922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited sodium channelopathies: a continuum of channel dysfunction.
    Viswanathan PC; Balser JR
    Trends Cardiovasc Med; 2004 Jan; 14(1):28-35. PubMed ID: 14720472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 12. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel.
    Surber R; Hensellek S; Prochnau D; Werner GS; Benndorf K; Figulla HR; Zimmer T
    Cardiovasc Res; 2008 Mar; 77(4):740-8. PubMed ID: 18065446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sodium channel and inherited arrhythmia syndromes.
    Bezzina CR; Rook MB; Wilde AA
    Cardiovasc Res; 2001 Feb; 49(2):257-71. PubMed ID: 11164836
    [No Abstract]   [Full Text] [Related]  

  • 15. Computer simulation of wild-type and mutant human cardiac Na+ current.
    Vecchietti S; Rivolta I; Severi S; Napolitano C; Priori SG; Cavalcanti S
    Med Biol Eng Comput; 2006 Mar; 44(1-2):35-44. PubMed ID: 16929919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.
    Veldkamp MW; Viswanathan PC; Bezzina C; Baartscheer A; Wilde AA; Balser JR
    Circ Res; 2000 May; 86(9):E91-7. PubMed ID: 10807877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation.
    Grant AO; Carboni MP; Neplioueva V; Starmer CF; Memmi M; Napolitano C; Priori S
    J Clin Invest; 2002 Oct; 110(8):1201-9. PubMed ID: 12393856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction.
    Wood DM; Dargan PI; Hoffman RS
    Clin Toxicol (Phila); 2009 Jan; 47(1):14-23. PubMed ID: 18815938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of sodium channel function.
    Tan HL; Bezzina CR; Smits JP; Verkerk AO; Wilde AA
    Cardiovasc Res; 2003 Mar; 57(4):961-73. PubMed ID: 12650874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.